Rchr
J-GLOBAL ID:201401049906022939
Update date: Oct. 21, 2021
Kono Masayuki
Kono Masayuki
Contact this researcher
You can send email directly to the researcher.
Affiliation and department:
Kyoto University
About Kyoto University
Search "Kyoto University"
Papers (32):
Osamu Kikuchi, Shinya Ohashi, Tomohisa Horibe, Masayuki Kohno, Yukie Nakai, Shin'ichi Miyamoto, Tsutomu Chiba, Manabu Muto, Koji Kawakami. Novel EGFR-targeted strategy with hybrid peptide against oesophageal squamous cell carcinoma. SCIENTIFIC REPORTS. 2016. 6. 22452
Arong Gaowa, Tomohisa Horibe, Masayuki Kohno, Hiroshi Harada, Masahiro Hiraoka, Koji Kawakami. Potent anti-tumor effects of EGFR-targeted hybrid peptide on mice bearing liver metastases. CLINICAL & EXPERIMENTAL METASTASIS. 2016. 33. 1. 87-95
Arong Gaowa, Tomohisa Horibe, Masayuki Kohno, Yasuhiko Tabata, Hiroshi Harada, Masahiro Hiraoka, Koji Kawakami. Enhancement of anti-tumor activity of hybrid peptide in conjugation with carboxymethyl dextran via disulfide linkers. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 2015. 92. 228-236
Masayuki Kohno, Tomohisa Horibe, Koji Ohara, Shinji Ito, Koji Kawakami. The Membrane-Lytic Peptides K8L9 and Melittin Enter Cancer Cells via Receptor Endocytosis following Subcytotoxic Exposure. CHEMISTRY & BIOLOGY. 2014. 21. 11. 1522-1532
Tomohisa Horibe, Aya Torisawa, Masayuki Kohno, Koji Kawakami. Synergetic cytotoxic activity toward breast cancer cells enhanced by the combination of Antp-TPR hybrid peptide targeting Hsp90 and Hsp70-targeted peptide. BMC CANCER. 2014. 14. 615
more...
Patents (2):
「EGFRを標的にした新規抗癌キメラペプチド」
「Hsp90を標的にした新規抗癌キメラペプチド」
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM